Cargando…

Consecutive versus concomitant follicle-stimulating hormone and highly purified human menopausal gonadotropin: A milder response but better quality

OBJECTIVE: This study investigated the impact of two stimulation protocols using highly purified human menopausal gonadotropin (HP-hMG) on the endocrine profile, follicular fluid soluble Fas levels, and outcomes of intracytoplasmic sperm injection (ICSI) cycles. METHODS: This prospective clinical tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maghraby, Hassan Ali, Agameya, Abdel Fattah Mohamed, Swelam, Manal Shafik, El Dabah, Nermeen Ahmed, Ahmed, Ola Youssef
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society for Reproductive Medicine 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184884/ https://www.ncbi.nlm.nih.gov/pubmed/35698776 http://dx.doi.org/10.5653/cerm.2021.05155

Ejemplares similares

Endocrine profile following stimulation with recombinant follicle stimulating hormone and luteinizing hormone versus highly purified human menopausal gonadotropin
por: Requena, Antonio, et al.
Publicado: (2014)

Economic evaluation of highly purified human menopausal gonadotropin versus recombinant human follicle-stimulating hormone in fresh and frozen in vitro fertilization/intracytoplasmic sperm-injection cycles in Sweden
por: Wex, Jaro, et al.
Publicado: (2013)

Highly Purified Human Menopausal Gonadotropin (HP-hMG) Versus Recombinant Follicle-Stimulating Hormone (rFSH) for Controlled Ovarian Stimulation in US Predicted High-Responder Patients: A Cost-Comparison Analysis
por: Khair, Andrew, et al.
Publicado: (2023)

The Menopausal Transition: Is the Hair Follicle “Going through Menopause”?
por: Rinaldi, Fabio, et al.
Publicado: (2023)

Omicron severity: milder but not mild
por: Nealon, Joshua, et al.
Publicado: (2022)

A Case of Suspected Isolated Follicle-Stimulating Hormone (FSH) Deficiency Where Spermatogenesis Was Acquired by Human Menopausal Gonadotropin (hMG)
por: Sugie, Miho, et al.
Publicado: (2023)

Comparison of recombinant human follicle stimulating hormone (rhFSH), human chorionic gonadotropin (HCG) and human menopausal gonadotropin (HMG) on semen parameters after varicocelectomy: a randomized clinical trial
por: Amirzargar, Mohammad Ali, et al.
Publicado: (2012)

First pre-filled pen device with highly purified human menopausal gonadotropin (HP-hMG, Menopur) in liquid is shown to be bioequivalent to powder for reconstitution
por: Jonker, Daniël M., et al.
Publicado: (2021)

Analysis of Nurse and Patient Preferences for Pre-Filled Pen Devices for Self-Injection of Highly Purified Human Menopausal Gonadotropin (HP-hMG, MENOPUR(®))
por: De Mesmaeker, Guy, et al.
Publicado: (2023)

Human menopausal gonadotropin-induced bioprosthetic valve thrombosis
por: Abazid, Rami Mahmood, et al.
Publicado: (2018)

Efficacy of Follicle-Stimulating Hormone (FSH) Alone, FSH + Luteinizing Hormone, Human Menopausal Gonadotropin or FSH + Human Chorionic Gonadotropin on Assisted Reproductive Technology Outcomes in the “Personalized” Medicine Era: A Meta-analysis
por: Santi, Daniele, et al.
Publicado: (2017)

Comparative effectiveness of recombinant human follicle-stimulating hormone alfa (r-hFSH-alfa) versus highly purified urinary human menopausal gonadotropin (hMG HP) in assisted reproductive technology (ART) treatments: a non-interventional study in Germany
por: Bühler, Klaus F., et al.
Publicado: (2021)

Commentary: Efficacy of Follicle-Stimulating Hormone (FSH) Alone, FSH + Luteinizing Hormone, Human Menopausal Gonadotropin or FSH + Human Chorionic Gonadotropin on Assisted Reproductive Technology Outcomes in the “Personalized” Medicine Era: A Meta-analysis
por: Younis, Johnny S.
Publicado: (2017)

A Comparison of Outcomes from In Vitro Fertilization Cycles Stimulated with Follicle Stimulating Hormone Plus either Recombinant Luteinizing Hormone or Human Menopausal Gonadotropins in Subjects Treated with Long Gonadotropin Releasing Hormone Agonist Protocols
por: Bleau, Nathalie, et al.
Publicado: (2017)

Omicron infection milder in nursing home residents
por: Katz, Morgan J, et al.
Publicado: (2022)

Therapierefraktäre Hypernatriämie bei milder COVID-19
por: Künzler, T., et al.
Publicado: (2021)

Response: Commentary: Efficacy of Follicle-Stimulating Hormone (FSH) Alone, FSH + Luteinizing Hormone, Human Menopausal Gonadotropin or FSH + Human Chorionic Gonadotropin on Assisted Reproductive Technology Outcomes in the “Personalized” Medicine Era: A Meta-analysis
por: Santi, Daniele, et al.
Publicado: (2018)

Efficacy and safety of human chorionic gonadotropin combined with human menopausal gonadotropin and a gonadotropin-releasing hormone pump for male adolescents with congenital hypogonadotropic hypogonadism
por: Liu, Ying, et al.
Publicado: (2021)

Distribution of binding sites for human chorionic gonadotropin in the preovulatory follicle of the rat
Publicado: (1975)

Gonadotropin ratio affects the in vitro growth of rhesus ovarian preantral follicles
por: Kim, Yoon Young, et al.
Publicado: (2016)

Milder disease with Omicron: is it the virus or the pre-existing immunity?
por: Sigal, Alex
Publicado: (2022)

Milder COVID-19 in children with inborn errors of immunity
por: Yadav, Anjali, et al.
Publicado: (2022)

Endocrine and molecular milieus of ovarian follicles are diversely affected by human chorionic gonadotropin and gonadotropin-releasing hormone in prepubertal and mature gilts
por: Ziecik, Adam J., et al.
Publicado: (2021)

Human recombinant follicle stimulating hormone (rFSH) compared to urinary human menopausal gonadotropin (HMG) for ovarian stimulation in assisted reproduction: a literature review and cost evaluation
por: Levi Setti, P. E., et al.
Publicado: (2014)

The role of pituitary gonadotropins and intraovarian regulators in follicle development: A mini‐review
por: Orisaka, Makoto, et al.
Publicado: (2021)

Synchronization of estrus using progesterone injections followed by human menopausal gonadotropin in ewes
por: Seidi Samani, Hassan, et al.
Publicado: (2023)

Subcutaneously administered Menopur(R), a new highly purified human menopausal gonadotropin, causes significantly fewer injection site reactions than Repronex(R) in subjects undergoing in vitro fertilization
por: Keye, William R, et al.
Publicado: (2005)

Milder forms of muscular dystrophy associated with POMGNT2 mutations
por: Endo, Yukari, et al.
Publicado: (2015)

Proteomic approach for understanding milder neurotoxicity of Carfilzomib against Bortezomib
por: Karademir, Betul, et al.
Publicado: (2018)

Very Low Residual Dystrophin Quantity Is Associated with Milder Dystrophinopathy
por: de Feraudy, Yvan, et al.
Publicado: (2020)

Why is the SARS-CoV-2 Omicron variant milder?
por: Xia, Bingqing, et al.
Publicado: (2022)

Genetic markers of ovarian follicle number and menopause in women of multiple ethnicities
por: Schuh-Huerta, Sonya M., et al.
Publicado: (2012)

Adrenocorticotropic Hormone Suppresses Gonadotropin-Stimulated Estradiol Release from Zebrafish Ovarian Follicles
por: Alsop, Derek, et al.
Publicado: (2009)

Gonadotropin treatment augments postnatal oogenesis and primordial follicle assembly in adult mouse ovaries?
por: Bhartiya, Deepa, et al.
Publicado: (2012)

Expression of Transcripts in Marmoset Oocytes Retrieved during Follicle Isolation Without Gonadotropin Induction
por: Kim, Yoon Young, et al.
Publicado: (2019)

Equine Chorionic Gonadotropin as an Effective FSH Replacement for In Vitro Ovine Follicle and Oocyte Development
por: Di Berardino, Chiara, et al.
Publicado: (2021)

Effects of human menopausal gonadotropin on zona pellucida and pregnancy outcomes of ovarian stimulation protocols
por: He, Bing, et al.
Publicado: (2015)

Association of GRIA1 polymorphisms with ovarian response to human menopausal gonadotropin in Iranian women
por: Golestanpour, Hossein, et al.
Publicado: (2020)

Incidence and concomitant chondral injuries in a consecutive cohort of primary traumatic patellar dislocations examined with sub-acute MRI
por: Isacsson, Anders, et al.
Publicado: (2023)

Randomized Pharmacokinetic Study of a Highly Purified Human Chorionic Gonadotropin and of a Recombinant Human Chorionic Gonadotropin Following Single Subcutaneous Administration in Healthy Women
por: Radicioni, Milko, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c3f2dks3v51m79o36nr3s4p6u2